Article Information
History
- December 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Caigang Liu1,*,
- Hong Yu1,#,
- Guanglei Chen1,#,
- Qichao Yang2,
- Nan Niu1,
- Ling Han3,
- Dongyu Zhao4,
- Manji Wang5,*,
- Yuanyuan Liu6 and
- Yongliang Yang2,*
- 1Cancer Stem Cell and Translation Medicine Lab, Innovative Cancer Drug Research and Development Engineering Center of Liaoning Province, Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, China
- 2School of Bioengineering, Dalian University of Technology, Dalian, 116023, China
- 3National Engineering Research Center of Pharmaceutics of Traditional Chinese Medicine, China Resources Sanjiu Medical & Pharmaceutical Co., Ltd, Shenzhen, China
- 4International Cancer Institute, Peking University Health Science Center, Peking University, Beijing, 100191, China
- 5Shanghai BeautMed Corporation, Shanghai, 200030, China
- 6Department of Biology, University of Copenhagen, Denmark
- ↵*To whom correspondence may be addressed: Caigang Liu
, E-mail: angel-s205@163.com; Address:
Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, China (lead contact)
, Manji Wang
, E-mail: 147304368{at}qq.com, Yongliang Yang
, E-mail: everbright99{at}foxmail.com
↵# These authors contributed equally to the work.
Posted December 06, 2022.
An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: a nonrandomized controlled trial
